Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Millions	Total	Total	Common Shares	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Deferred Equity Compensation	Nonredeemable Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2022			59,013,040
Beginning balance at Dec. 31, 2022	$ 5,292	$ 5,064	$ 1	$ 5,577	$ (515)	$ 1	$ 228
Increase (Decrease) in Shareholders' Equity
Net income	97	81		81			16
Dividends	(18)	(18)		(18)
Contributions	3						3
Common share repurchases (in shares)			(36,369)
Common shares repurchases	(2)	(2)		(2)
Shared based compensation (in shares)			297,441
Distributions	(52)						(52)
Other comprehensive (loss) income	95	95			95
Ending balance (in shares) at Mar. 31, 2023			59,274,112
Ending balance at Mar. 31, 2023	5,415	5,220	$ 1	5,638	(420)	1	195
Beginning balance (in shares) at Dec. 31, 2023			56,217,305
Beginning balance at Dec. 31, 2023	5,765	5,713	$ 1	6,070	(359)	1	52
Increase (Decrease) in Shareholders' Equity
Net income	113	109		109			4
Dividends	(19)	(19)		(19)
Common share repurchases (in shares)			(1,539,278)
Common shares repurchases	(131)	(131)		(131)
Distributions	(3)						(3)
Other comprehensive (loss) income	(28)	(28)			(28)
Ending balance (in shares) at Mar. 31, 2024			55,081,584
Ending balance at Mar. 31, 2024	5,682	5,629	$ 1	6,014	$ (387)	$ 1	$ 53
Increase (Decrease) in Shareholders' Equity
Stock Issued During Period, Shares, Share-based Compensation and Other			403,557
Stock Issued During Period, Value, Share-based Compensation and Other	$ (15)	$ (15)		$ (15)